Greenwich LifeSciences
GLSI
28 hedge funds and large institutions have $11.4M invested in Greenwich LifeSciences in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 0 closing their positions.
27% more funds holding
Funds holding: 22 → 28 (+6)
12% more capital invested
Capital invested by funds: $10.2M → $11.4M (+$1.21M)
1.22% more ownership
Funds ownership: 5.22% → 6.44% (+1.2%)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$589K |
| 2 |
Millennium Management
New York
|
+$541K |
| 3 |
HF
HRT Financial
New York
|
+$295K |
| 4 |
Jane Street
New York
|
+$294K |
| 5 |
Renaissance Technologies
New York
|
+$278K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$57.9K |
| 2 |
Morgan Stanley
New York
|
-$25.4K |
| 3 |
6CM
683 Capital Management
New York
|
-$15.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$11.5K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9.38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $331 | – | – | – |
|
|
27
UBS Group
Zurich,
Switzerland
| $14 | -$11.5K | -723 | -100% |
|
GLSI Hedge Fund Activity: Q1 2023 in Review
28 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q1 2023, worth a combined $11.4M — up 12% from $10.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new GLSI positions and 0 closed out — a net gain of 6 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $589K. The largest seller was Bank of America, cutting an estimated $57.9K.
- 28 institutional investors held Greenwich LifeSciences (GLSI) as of Q1 2023, up from 22 in Q4 2022.
- Funds reported $11.4M of Greenwich LifeSciences stock for Q1 2023, up 12% quarter-over-quarter.
- 6 funds opened new Greenwich LifeSciences positions in Q1 2023 and 0 closed out, a net change of +6 holders.
- The largest Greenwich LifeSciences buyer in Q1 2023 was Susquehanna International Group, an estimated $589K added.
- The largest Greenwich LifeSciences seller in Q1 2023 was Bank of America, an estimated $57.9K sold.
Based on aggregated 13F filings for Q1 2023.